BACKGROUND: Despite considerable advances following the introduction of highly active antiretroviral therapy, organ transplantation is usually denied categorically for human immunodeficiency virus (HIV) patients, and it is presented in German transplantation law as a contraindication. Today, this should be questioned critically. METHOD: A survey at all 87 German transplant centres was done concerning (1) how many HIV-positive patients were transplanted before and after February 2000, (2) willingness of the centres to transplant HIV-infected patients in the future, and (3) course of transplanted HIV patients so far. RESULTS: With a response rate of 78%, 39% of the questioned centres were accepting HIV patients in the future for transplantation, and 39% rejected this. Twenty percent voted for individual case decision. Three centres had practiced liver transplantation in 11 patients. CONCLUSION: The decision to transplant HIV-positive patients in Germany is mostly based on individual cases and not refused in general. However, prospective studies on this issue are justified and needed.
BACKGROUND: Despite considerable advances following the introduction of highly active antiretroviral therapy, organ transplantation is usually denied categorically for human immunodeficiency virus (HIV) patients, and it is presented in German transplantation law as a contraindication. Today, this should be questioned critically. METHOD: A survey at all 87 German transplant centres was done concerning (1) how many HIV-positive patients were transplanted before and after February 2000, (2) willingness of the centres to transplant HIV-infectedpatients in the future, and (3) course of transplanted HIVpatients so far. RESULTS: With a response rate of 78%, 39% of the questioned centres were accepting HIVpatients in the future for transplantation, and 39% rejected this. Twenty percent voted for individual case decision. Three centres had practiced liver transplantation in 11 patients. CONCLUSION: The decision to transplant HIV-positive patients in Germany is mostly based on individual cases and not refused in general. However, prospective studies on this issue are justified and needed.
Authors: J S Dummer; S Erb; M K Breinig; M Ho; C R Rinaldo; P Gupta; M V Ragni; A Tzakis; L Makowka; D Van Thiel Journal: Transplantation Date: 1989-01 Impact factor: 4.939
Authors: A A Prachalias; A Pozniak; C Taylor; P Srinivasan; P Muiesan; J Wendon; M Cramp; R Williams; J O'Grady; M Rela; N D Heaton Journal: Transplantation Date: 2001-11-27 Impact factor: 4.939
Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245
Authors: E L Ramos; B L Kasiske; S R Alexander; G M Danovitch; W E Harmon; L Kahana; T J Kiresuk; J F Neylan Journal: Transplantation Date: 1994-02-27 Impact factor: 4.939
Authors: Ashokkumar B Jain; Raman Venkataramanan; Bijan Eghtesad; Amadeo Marcos; Margaret Ragni; Ron Shapiro; Ann B Rafail; John J Fung Journal: Liver Transpl Date: 2003-09 Impact factor: 5.799